Peter Deleeuw, DO
Gastroenterology · Huntsville, ALNPI 1710411541
Payments from drug & device makers
Across 153 payments — averaging $22.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$710
- Madrigal Pharmaceuticals$654
- Johnson & Johnson$408
- Sanofi$322
- Takeda Pharmaceuticals U.S.A., Inc.$249
- QOL Medical, LLC$192
- plus $854 from 12 others
What the payments were for
- Food & beverage$3,374100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $710 |
| Madrigal Pharmaceuticals | 18 | $654 |
| Johnson & Johnson | 22 | $408 |
| Sanofi | 10 | $322 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $249 |
| QOL Medical, LLC | 7 | $192 |
| Regeneron Healthcare Solutions, Inc. | 4 | $170 |
| Gilead | 7 | $154 |
| Medtronic | 1 | $132 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $117 |
| Phathom Pharmaceuticals, Inc. | 14 | $111 |
| Intercept Pharmaceuticals, Inc. | 2 | $39 |
| Ardelyx, Inc. | 2 | $38 |
| Exact Sciences | 2 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Celltrion USA Inc. | 1 | $15 |
| Evoke Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,389 in reported general payments places this provider in the 40th percentile of 225 gastroenterology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexlansoprazole DrDexlansoprazole | 16 | $4,064 |
| Pantoprazole Sodium | 68 | $1,300 |
| Omeprazole | 11 | $115 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Huntsville
- Michael DohrenwendHuntsville$57K
- John-Paul VoelkelHuntsville$17K
- Meredith RoathHuntsville$16K
- Smita ShahHuntsville$16K
- Charles BillingsHuntsville$16K
- Dino FerranteHuntsville$15K
- Suresh KarneHuntsville$12K
- Rami HawariHuntsville$10K
- Prasad VankineniHuntsville$10K
- Eghierhua UgheokeHuntsville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.